Filter
378
Filtered Results: 378
Text search:
Ethiopian
Food
and
Drug
Authority
Featured
Recommendations
41
New Publications
117
Language
Document type
No document type
203
Studies & Reports
81
Guidelines
48
Strategic & Response Plan
25
Manuals
14
Fact sheets
3
Training Material
2
Situation Updates
1
Resource Platforms
1
Countries / Regions
Ethiopia
74
Global
25
Kenya
18
Africa
13
Uganda
9
Ghana
8
Nigeria
8
Malawi
7
Zambia
7
Liberia
6
Sierra Leone
5
Tanzania
5
South Africa
5
Rwanda
4
Congo, Democratic Republic of
4
South–East Asia Region
4
Namibia
4
Lesotho
3
Latin America and the Carribbean
3
West and Central Africa
3
Middle East and North Africa
3
Sudan
3
Pakistan
3
Mexico
2
Syria
2
Iran
2
Zimbabwe
2
Guinea
2
Jordan
2
Western and Central Europe
2
South Sudan
2
India
2
Myanmar / Burma
2
North Macedonia
1
Thailand
1
Ukraine
1
China
1
Albania
1
Burkina Faso
1
Afghanistan
1
Morocco
1
Philippines
1
Mozambique
1
Italy
1
Cambodia
1
Venezuela
1
Saudi Arabia
1
Eastern Europe and Central Asia
1
Tunisia
1
East and Southern Africa
1
Lebanon
1
Bangladesh
1
Moldova
1
Yemen
1
Greece
1
Palestine
1
Georgia
1
Central African Republic
1
Libya
1
Botswana
1
Indonesia
1
Iraq
1
Somalia
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
133
Clinical Guidelines
37
Public Health
28
Key Resources
25
Women & Child Health
22
Capacity Building
7
Pharmacy & Technologies
6
Toolboxes
TB
37
HIV
34
Mental Health
23
Pharmacy
22
NTDs
19
AMR
19
COVID-19
17
Refugee
12
Rapid Response
10
Planetary Health
10
NCDs
8
Global Health Education
8
Caregiver
7
Conflict
7
Cholera
5
Health Financing Toolbox
4
Disability
3
Ebola & Marburg
3
Malaria
2
Polio
2
Specific Hazards
1
Natural Hazards
1
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G...
This short paper aims to identify key evidence gaps in our knowledge of livestock- and fisheries-linked antimicrobial resistance in the developing world, and to document on-going or planned research initiatives on this topic by key stakeholders.
The antimicrobial resistant (AMR) infections in anima...
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically assist national medicines regulatory authorities to...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
Participant Modules
This working paper was conceived to offer practical tips and suggestions on how to establish and sustain the multisectoral coordination needed to develop and implement National Action Plans on AMR (NAPs). It is intended for anyone with responsibility for addressing AMR at country level. Drawing on b...
Survey of the Quality of Selected Antimalarial Medicines Circulating in Six Countries of Sub-Saharan Africa
recommended
The survey aimed at evaluating the quality of selected antimalarials in six countries of sub-Saharan Africa (Cameroon, Ethiopia, Ghana, Kenya, Nigeria and the United Republic of Tanzania). These countries have been supported by WHO to strengthen their regulatory controls o...
This working paper was conceived to offer practical tips and suggestions on how to establish and sustain the multisectoral coordination needed to develop and implement National Action Plans on AMR (NAPs). It is intended for anyone with responsibility for addressing AMR at country level. Drawing on b...
In many low- and middle-income countries, there is a wide gap between evidencebased recommendations and current practice. Treatment of major CVD risk factors remains suboptimal, and only a minority of patients who are treated reach their target levels for blood pressure, blood sugar and blood choles...
Crisis Group’s Watch List identifies ten countries or regions at risk of deadly conflict or escalation thereof in 2021. In these places, early action, driven or supported by the EU and its member states, could enhance prospects for peace and stability.
Crisis Group’s early-warning Watch List id...
The present guidelines incorporate all these changes, leading to a substantial reconfiguration of therapeutic choices for both disease forms.
HAT is a serious, life-threatening disease and the efficacy of fexinidazole depends on swallowing the medicine after an appropriate intake of food as well as...
The WHO standard: Universal access to rapid tuberculosis diagnostics sets benchmarks to achieve universal access to WHO-recommended rapid diagnostics (WRDs), increase bacteriologically confirmed tuberculosis and drug resistance detection, and reduce the time to diagnosis. WHO-recommended rapid diagn...
Trachoma is the leading infectious cause of blindness worldwide. In April 2023, it was a public health problem
in approximately 40 countries, with an estimated 116 million people at risk and 1.5 million people affected
by the late blinding stage of the disease (1). About 84% of those at risk of tr...
Full eHandbook under: http://www.msh.org/resources/health-systems-in-action-an-ehandbook-for-leaders-and-managers
Effective supply management has the potential to make a powerful contribution to the reliable availability of essential medicines, which are a crucial part of the delivery of highqualit...
A survey of prevention, testing and treatment policies and practices
